[The significance of choroidal neovascularization type in predicting the effectiveness of antiangiogenic therapy]

Neovascular age-related macular degeneration (nAMD) is one of the causes of irreversible visual acuity loss. Intravitreal injections of anti-vascular endothelium growth factor (anti-VEGF agents) have been proved to be an effective treatment of nAMD. Among the topical problems of this type of treatment is the possibility for predicting the response of different types of choroidal neovascularization (CNV) to the anti-VEGF therapy. This article discusses the differences in the dynamics of morphological and functional parameters of various types of neovascular membranes in the process of anti-VEGF therapy.